EUROAPI SA engages in manufacturing and supply of active pharmaceutical ingredient solutions for healthcare companies. The company is headquartered in Paris, Ile-De-France. The company went IPO on 2022-05-06. The firm is engaged in the development, manufacture and supply of active-ingredient solutions to its healthcare partners. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc. ), analgesics, etc. The firm also provides technologies and develops molecules through it’s Contract Development and Manufacturing Organization (CDMO). It’s CDMO services include Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones and Opiates & Controlled Substances. The company has production sites located in France, the United Kingdom, Germany, Italy and Hungary.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenue
852
852
919
1,018
980
892
Revenue Growth (YoY)
-7%
-7%
-10%
4%
10%
-6%
Cost of Revenue
707
707
776
854
804
783
Gross Profit
144
144
142
164
176
109
Selling, General & Admin
115
115
127
130
128
89
Research & Development
27
27
25
29
21
17
Operating Expenses
141
141
150
160
149
107
Other Non Operating Income (Expenses)
-2
0
-17
-7
-1
0
Pretax Income
-138
-138
-139
-242
3
-14
Income Tax Expense
72
72
-9
-53
18
-6
Net Income
-211
-211
-130
-189
-15
-8
Net Income Growth
62%
62%
-31%
1,160%
88%
33%
Shares Outstanding (Diluted)
94.8
94.7
94.5
94.2
93.7
90
Shares Change (YoY)
0%
0%
0%
1%
4%
0%
EPS (Diluted)
-2.22
-2.23
-1.38
-2.01
-0.16
-0.09
EPS Growth
61%
61%
-31%
1,159%
78%
28.99%
Free Cash Flow
50
50
14
-127
-122
-16
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
16.9%
16.9%
15.45%
16.11%
17.95%
12.21%
Operating Margin
0.35%
0.35%
-0.87%
0.39%
2.75%
0.11%
Profit Margin
-24.76%
-24.76%
-14.14%
-18.56%
-1.53%
-0.89%
Free Cash Flow Margin
5.86%
5.86%
1.52%
-12.47%
-12.44%
-1.79%
EBITDA
143
143
68
306
121
77
EBITDA Margin
16.78%
16.78%
7.39%
30.05%
12.34%
8.63%
D&A For EBITDA
140
140
76
302
94
76
EBIT
3
3
-8
4
27
1
EBIT Margin
0.35%
0.35%
-0.87%
0.39%
2.75%
0.11%
Effective Tax Rate
-52.17%
-52.17%
6.47%
21.9%
600%
42.85%
Follow-Up Questions
What are Euroapi SA's key financial statements?
According to the latest financial statement (Form-10K), Euroapi SA has a total asset of $1,304, Net loss of $-211
What are the key financial ratios for EAPIF?
Euroapi SA's Current ratio is 2.52, has a Net margin is -24.76, sales per share of $8.99.
How is Euroapi SA's revenue broken down by segment or geography?
Euroapi SA largest revenue segment is Complex Chemical Synthesis Molecules, at a revenue of 656,200,000 in the most earnings release.For geography, France is the primary market for Euroapi SA, at a revenue of 1,018,900,000.
Is Euroapi SA profitable?
no, according to the latest financial statements, Euroapi SA has a net loss of $-211
Does Euroapi SA have any liabilities?
yes, Euroapi SA has liability of 516
How many outstanding shares for Euroapi SA?
Euroapi SA has a total outstanding shares of 95.21